Effect of Fermented Traditional Chinese Prescription With Lactobacillus Plantarum on Dysbacteriotic Diarrhea Mice Induced by Ceftriaxone Sodium

Background: Buzhongyiqi decoction (B), Sijunzi decoction (S), and Shenlingbaizhu decoction (SH) have been extensively clinically used for the treatment of health status and diseases caused by spleen-qi deficiency for many years and microbial fermentation has been widely applied in Traditional Chinese Medicine (TCM) for thousands of years in China. This study was aimed to investigate the mitigative effect of TCM and fermented TCM (FTCM) with Lactobacillus plantarum (LP) in antibiotic-associated diarrhea (AAD), and identify the compounds of S and Fermented S (FS). Methods: The dysbacteriotic diarrhea mice induced by ceftriaxone sodium (CS) were treated with LP, B, S, SH, Fermented B, S, and SH. The diarrhea indexes, the abundance of some gut bacteria, intestinal morphometrics, and the mRNA expressions related to intestinal barrier function were assessed at multilevels. In addition, S and FS were chosen to identify and relatively quantify the compounds by ultra-high-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry (UHPLC-Q-TOF/MS), and different expressed compounds were analysed. Results: Results showed that CS significantly increased the fecal output weight, the total number of fecal output, and fecal water content, indicating the occurrence of diarrhea, while TCM, LP, and FTCM alleviated the diarrhea to different degrees and FTCM showed more sustained effects. Then, bacterial culture test showed above symptoms were accompanied with the disruption of some intestinal flora. Meanwhile, the diarrhea mice showed abnormal intestinal morphology and destroyed intestinal barrier manifested as reduced mRNA expression of Aquaporins (AQPs) and tight junction (TJ) protein. Notably, the above indices were alleviated in other treatments mice.Conclusions: All these findings imply that the intestinal side effects caused by antibiotics can be alleviated by TCM, LP, and fermented TCM through regulating the intestinal flora and barrier function, which provides an idea of further development and application of them in the clinical use of antibiotics.

PSV-B-21 Evaluation of whole soybeans as an ingredient in dog diets: Apparent total tract digestibility and stool quality of extruded diets with graded levels of dehulled whole soybeans by dogs

Increasing the amount of liquid fat to the ration during extrusion can negatively affect product density and product expansion. Ingredients, like whole soybeans (WSB), which are high in fat may aid increased energy density while avoiding production issues. In a preliminary extrusion project, the effects on the process of foods were evaluated, followed by animal evaluation. The objective of this study was to determine the effect of dehulled WSB on nutrient digestibility and stool quality by dogs. Experimental diets were extruded with 0%, 10%, 20%, and 30% WSB (WSB0, WSB10, WSB20, and WSB30, respectively). Seven castrated male and three spayed female Beagles of similar age (6.25 ± 0.452 years) were individually housed and fed the experimental diets. The study was designed as replicated 4 × 4 Latin square where dogs were allowed 9-d adaptation followed by 5-d total fecal collection for each period. Titanium dioxide was added to all diets (0.4%) to serve as an indigestible dietary marker to determine apparent total tract digestibility (ATTD). Least-square means of fecal parameters and ATTD were analyzed with a single degree of freedom contrasts and significance at α = 0.05. There was no difference among treatments for food intake or fecal scores. However, there were linear increases (P < 0.05) in DM fecal output, as is fecal output, fecal moisture, and defecation frequency stools/day as WSB increased in the diets. Apparent total tract digestibility of dry matter, crude protein, acid hydrolyzed ether extract, and gross energy decreased linearly as dogs were fed increasing levels of WSB in the diets (P < 0.05). In conclusion, additional thermal processing before extrusion may improve nutrient digestibility, although stool quality was not affected by the inclusion of WSB.

Antidiarrheal Activity of Four Different Species of Litsea Available in Bangladesh

The objective of the present study includes the evaluation of the antidiarrheal properties of the methanol extracts of Litsea deccanensis Gamble (MELD) bark, Litsealancifolia (Roxb.) Hook. f. MELL),Litseaglutinosa Gamble (MELG) and Litsea monopetala Roxb. (MELM) leavesin Swiss albino mice. The antidiarrheal activity was evaluated by measuring percentage inhibition of diarrheal feces, total fecal output, gastrointestinal motility and by using peristaltic indices. Castor oil was used to induce diarrhea in the experimental animal. The experiments were carried out by using three different doses (100, 200, and 400 mg/kg body weight) of these four plant extracts. The number of wet feces and total weight of the feces were significantly (p < 0.05) and dose-dependently reduced by all the plant extracts and this effect was comparable with standard drug. MELD, MELL, MELG and MELM extracts at dose of 400 mg/kg body weight demonstrated diarrheal inhibition by 43.55%, 45.16%, 32.26% and 41.94%, respectively while it was 98.39% for the standard loperamide. Percentage (%) of fecal output for MELD, MELL, MELG and MELM extracts at the dose of 400 mg/kg were 40.14%, 62.27%, 64.06%, 46.26%, respectively.The gastrointestinal motility induced by castor oil was also reduced noticeably (p < 0.05) by all the plant extracts with the increasing doses. The percentage inhibition of gastrointestinal motility at the dose of 400 mg/kg were 26.26%, 33.22%, 32.36% and 22.52% for the MELD, MELL, MELG and MELM extracts respectively, while it was 27.56% for loperamide. In most cases, all the plant extracts can reduce the peristaltic indices which were comparable to control. The obtained results from this study revealed that the methanol extracts of four different species of Litsea found in Bangladesh may have antidiarrheal potential. It also provides the basis for the traditional use of these plants to treat diarrhea.

Technical note: using an automated head chamber system to administer an external marker to estimate fecal output by grazing beef cattle

The objective of this experiment was to determine if titanium dioxide (TiO2) dosed through an automated head chamber system (GreenFeed; C-Lock Inc., Rapid City, SD USA) is an acceptable method to measure fecal output. The GreenFeed used on this experiment had a 2hopper bait dispensing system where hopper 1 contained alfalfa pellets marked with 1% titanium dioxide (TiO2) and hopper 2 contained unmarked alfalfa pellets. Eleven heifers (BW = 394 ± 18.7 kg) grazing a common pasture were stratified by BW and then randomized to either 1) dosed with TiO2-marked pellets by hand feeding (HFD; n = 6) or 2) dosed with TiO2-marked pellets by the GreenFeed (GFFD; n = 5) for 19 d. During the morning (0800), all heifers were offered a pelleted, high-CP supplement at 0.25% of BW in individual feeding stanchions. The HFD heifers also received 32 g of TiO2-marked pellets at morning feeding, whereas the GFFD heifers received 32 g of unmarked pellets. The GFFD heifers received a single aliquot (32 ± 1.6 g; mean ± SD) of marked pellets at their first visit to the GreenFeed each day with all subsequent 32-g aliquots providing unmarked pellets; HFD heifers received only unmarked pellets. Starting on d 15, fecal samples were collected via rectal grab at feeding and every 12 h for 5 d. A two-one sided t-test method was used to determine agreement and it was determined that the fecal output estimates by HFD and GFFD methods were similar (P = 0.04). There was a difference (P &lt; 0.01; Bartlett’s test for homogenous variances) in variability between the dosing methods for HFD and GFFD (SD = 0.1 and 0.7, respectively). This difference in fecal output variability may have been due to variability of dosing times-of-day for the GFFD heifers (0615 ± 6.2 h) relative to the constant dosing time-of-day for HFD and constant 0800 and 2000 sampling times-of-day for all animals. This research has highlighted the potential for dosing cattle with an external marker through a GreenFeed configured with two (or more) feed hoppers because estimated fecal output means were similar; however, consideration of the increased variability of the fecal output estimates is needed for future experimental designs.

Comparative in-vivo Study of Laxative, Anti-diarrheoal and Anti-emetic activity of Ethanolic and Ethyl Acetate Leaf Extract of Citrus limon in Rats and Chicks

The aim of present work is to evaluate the laxative, anti-diarrhoeal and anti-emetic activity extract of Citrus limon by using different solvents like ethanol and ethyl-acetate. The methods employed are measuring fecal output in naive rats, loperamide induced constipation in rats, castor oil induced diarrhoea in rats and anti-emetic activity was evaluated using chick model. In fecal output in naive rats, the consistency of stools expelled within 24hrs after administration of extracts was observed. The loperamide induced constipation in rats using standard drug sodium picosulphate (5mg/kg), the faeces were collected after 8hrs and stool consistency was observed. At higher dose there is increase in fecal matter and compared with standard. The castor oil induced diarrhoea decreased total no. of feces was observed after 4hrs and these values are compared with control. In anti-emetic activity, the chicks after 10 minutes of copper sulphate pentahydrate(50mg/kg) administration there was an increase in no. of retchings (An emetic action without emeting gastric material) and the results are comparable with that of standard Chlorpromazine(150mg/kg).

Depletion of Gut Microbiota Suppresses the Metabolite Formation of Vitamin E Forms Including Delta-tocotrienol and Its Long-chain Metabolite 13’-carboxychromanol in Mice

Objectives We recently show that supplementation of delta-tocotrienol (δTE), a vitamin E form and its metabolite δTE-13’-carboxychromanol (δTE-13’) modulated gut microbiota and meanwhile increased metabolites in feces. Since gut microbiota has been shown to metabolize phenolic compounds, we hypothesize that gut bacteria may play a role in metabolizing δTE and δTE-13’. This hypothesis was addressed in the comparison of metabolites formation between antibiotic cocktail (ABX)-treated mice and non-ABX treated mice. Methods Male Balb/c mice were given ABX or water daily for 7 days to remove the gut microbiota. Subsequently ABX or water-treated mice were given a single gavage of δTE/gamma-tocotrienol (δTE/γTE at 8:1) or δTE-13’ at 42mg/kg bw. 24-hr later, mice were sacrificed. We collected 24-hr accumulative fecal samples, adipose, plasma, colon and liver tissues and quantified the concentrations of vitamin E forms and metabolites in these samples. Results Compared with non-ABX controls, ABX-treated mice had decreased weights of liver, spleen and colon, while had doubled the amount of 24-hr fecal output. In δTE-gavaged animals, ABX treatment decreased fecal amounts of δTE and its metabolites by 61% and 98% respectively, while increased δTE level in the adipose tissue. Similarly, in animals gavaged with δTE-13’, ABX treatment led to a 98% reduction in its downstream metabolites. Additionally, ABX treatment decreased fecal excretion of metabolites from other vitamin E forms including α, γ, δ-tocopherols and γTE. Conclusions These results demonstrate that without the gut microbiota, fecal concentrations of vitamin E metabolites declined dramatically, suggesting potential role of the gut microbiota in metabolizing vitamin E forms. Funding Sources Purdue Center for Cancer Research.

161 Effects of Supplemental Zn Source (sulfate or Bis-glycinate) on Metabolism, Apparent Absorption, and Retention of Zn by Lambs

To assess bioavailability of bis-glycinate Zn (Plexomin Zn, Phytobiotics), 36 crossbred wethers (34 ± 2 kg) were sorted by body weight into three groups and stagger started on a Zn deplete diet (18.6 mg Zn/kg dry matter [DM]; 22.5% neutral detergent fiber) for 45 d prior to a 15-d metabolism period (10 d adaptation, 5 d collection). On d 46, lambs were randomly assigned to dietary Zn treatments (4 lambs/treatment/group): no supplemental Zn (CON) or 15 mg supplemental Zn/kg DM as Zn sulfate (ZS) or bis-glycinate Zn (GLY). Blood was collected from all lambs on d 1, 44, 56, and 61. Liver, small intestine, and muscle samples were collected after euthanasia on d 61. Liver and intestinal gene expression was determined via quantitative real-time polymerase chain reaction. Data were analyzed using ProcMixed of SAS (experimental unit = lamb; fixed effects = treatment, group, and breed). After 15 d of Zn supplementation, plasma Zn concentrations were greatest for GLY versus CON or ZS (P ≤ 0.01), but tissue Zn concentrations were unaffected (P ≥ 0.15). Liver MT1 expression was approximately 2-fold greater for GLY versus CON or ZS (P ≤ 0.07). Intestinal ZIP4 expression tended or was lesser for ZS or GLY versus CON (P ≤ 0.07) and ZNT1 expression tended to be lesser for ZS versus CON (P = 0.07). Zinc intake, fecal output, retention, and apparent absorption were greater for ZS or GLY versus CON (P ≤ 0.01). Apparent absorption of Zn was -5.1, 12.8, and 15.0% for CON, ZS, and GLY, respectively. Although Zn apparent absorption did not differ between supplemental Zn sources (P = 0.71), differences in post-absorptive metabolism may be responsible for the observed increase in circulating Zn concentrations and liver MT1 expression in GLY supplemented lambs, suggesting improved bioavailability of GLY relative to ZS.

Effects of Cisapride, Buprenorphine, and Their Combination on Gastrointestinal Transit in New Zealand White Rabbits

Due to their effective analgesic properties, opioids are worthy of consideration for pain management in rabbits. However, this class of drugs causes undesirable effects including reduced gastrointestinal (GI) motility, reduced fecal output, and delays GI transit times and thus increases the risk of GI stasis. The risk of stasis discourages the use of opioids in rabbits, which could affect animal welfare. Gastroprokinetic agents such as cisapride are effective in promoting gastric emptying in many species, but whether this effect occurs in rabbits is unknown. This study assessed the efficacy of cisapride when administered as a single agent and in combination with buprenorphine in rabbits; efficacy was assessed by measuring GI transit times, fecal output, body weight, and food and water intake. Female New Zealand White rabbits (n = 10) were studied in a crossover, randomized design and received either vehicle and buprenorphine, cisapride and saline, cisapride and buprenorphine, or vehicle and saline (control) every 8 h for 2 d. Rabbits were anesthetized and administered radio-opaque, barium-filled spheres via orogastric tube. Feces was assessed via radiography for detection of the barium-spheres to determine GI transit time. GI transit time was significantly longer in buprenorphine groups than in control groups, regardless of the use of cisapride. Fecal output and food and water intake were lower for buprenorphine groups than control groups. Cisapride did not significantly alter GI transit, fecal output, or food and water intake. In addition, treatment group did not significantly affect body weight. In conclusion, buprenorphine treatment (0.03 mg/kg TID) prolonged GI transit time and reduced fecal output and food and water consumption in rabbits. Coadministration of buprenorphine and cisapride (0.5 mg/kg) did not ameliorate these effects, and the administration of cisapride at this dose did not appear to affect GI motility in female rabbits.